| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000233255.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030235741 |
Resistant |
| ENSG00000233255.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007847607 |
Sensitive |
| ENSG00000233255.1 |
Ponatinib |
Stomach adenocarcinoma |
0.002447972 |
Sensitive |
| ENSG00000233255.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040967696 |
Resistant |
